Association of a polymorphism of BTN2A1 with dyslipidemia in community-dwelling individuals

Molecular Medicine Reports

Volumn 9, Issue 3, 2014, Pages 808-812

  Horibe, Hideki ^a   Ueyama, Chikara ^a   Fujimaki, Tetsuo ^b   Oguri, Mitsutoshi ^c   Kato, Kimihiko ^d,e   Ichihara, Sahoko ^e   Yamada, Yoshiji ^e  

^a GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^b Inabe General Hospital   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^d Meitoh Hospital   (Japan)

^e MIE UNIVERSITY   (Japan)

Author keywords

BTN2A1; Cohort study; Dyslipidemia; Genetics; Polymorphism

Indexed keywords

ADULT; AGE FACTORS; AGED; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; SEX FACTORS; SMOKING; TRIGLYCERIDES;

EID: 84893852455     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.1902     Document Type: Article

References (23)

1. Khera AV and Rader DJ: Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics. Trends Cardiovasc Med 19: 195-201, 2009.
2. Ordovas JM: Nutrigenetics, plasma lipids, and cardiovascular risk. J Am Diet Assoc 106: 1074-1081, 2006.
3. Stamler J, Wentworth D and Neaton JD: Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256: 2823-2828, 1986.
4. Pekkanen J, Linn S, Heiss G, Suchindran CM, Leon A, Rifkind BM and Tyroler HA: Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 322: 1700-1707, 1990.
5. Aulchenko YS, Ripatti S, Lindqvist I, et al: Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 41: 47-55, 2009.
6. Kathiresan S, Melander O, Guiducci C, et al: Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40: 189-197, 2008.
7. Kathiresan S, Willer CJ, Peloso GM, et al: Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41: 56-65, 2009.
8. Yamada Y, Nishida T, Ichihara S, et al: Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations. Atherosclerosis 215: 145-152, 2011.
9. Yamada Y, Matsuo H, Warita S, et al: Prediction of genetic risk for dyslipidemia. Genomics 90: 551-558, 2007.
10. Itoh Y, Mizuki N, Shimada T, et al: High-throughput DNA typing of HLA-A,-B,-C, and-DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 57: 717-729, 2005.
11. Smith DG. Epidemiology of dyslipidemia and economic burden on the healthcare system. Am J Manag Care 13 (Suppl 3): S68-S71, 2007.
12. World Health Organization: Quantifying selected major risks to health. In: The World Health Report 2002-Reducting Risks, Promoting Healthy Life. World Health Organization, Geneva, pp47-97, 2002.
13. Fujimaki T, Kato K, Oguri M, et al: Association of a polymorphism of BTN2A1 with dyslipidemia in East Asian populations. Exp Ther Med 2: 745-749, 2011.
14. Ogg SL, Weldon AK, Dobbie L, Smith AJ and Mather IH: Expression of butyrophilin (Btn1a1) in lactating mammary gland is essential for the regulated secretion of milk-lipid droplets. Proc Natl Acad Sci USA 101: 10084-10089, 2004.
15. Arnett HA, Escobar SS and Viney JL: Regulation of costimulation in the era of butyrophilins. Cytokine 46: 370-375, 2009.
16. Oguri M, Kato K, Yoshida T, et al: Association of a genetic variant of BTN2A1 with metabolic syndrome in East Asian populations. J Med Genet 48: 787-792, 2011.
17. Khovidhunkit W, Kim MS, Memon RA, et al: Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45: 1169-1196, 2004.
18. Esteve E, Ricart W and Frenándes-Real JM: Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 24: 16-31, 2005.
19. Gallin JI, Kaye D and O'Leary WM: Serum lipids in infection. N Engl J Med 281: 1081-1086, 1969.
20. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkilä E and Taskinen MR: Changes in serum lipoprotein pattern induced by acute infections. Metabolism 37: 859-865, 1988.
21. Chen X, Xun K, Chen L and Wang Y: TNF-alpha, a potent lipid metabolism regulator. Cell Biochem Funct 27: 407-416, 2009.
22. McGillicuddy FC, de la Llera Moya M, Hinkle CC, et al: Inflammation impairs reverse cholesterol transport in vivo. Circulation 119: 1135-1145, 2009.
23. Reiss AB: Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus. Curr Rheumatol Rep 11: 255-260, 2009.